Pyruvic acid-13C
Modify Date: 2024-01-11 20:43:52
Pyruvic acid-13C structure
|
Common Name | Pyruvic acid-13C | ||
|---|---|---|---|---|
| CAS Number | 99124-30-8 | Molecular Weight | 89.05470 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C3H4O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 179.6 °F | |
| Symbol |
GHS05 |
Signal Word | Danger | |
Use of Pyruvic acid-13CPyruvic acid-13C is the 13C labeled Pyruvic acid[1]. Pyruvic acid is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats[2]. |
| Name | 2-oxopropanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Pyruvic acid-13C is the 13C labeled Pyruvic acid[1]. Pyruvic acid is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats[2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C3H4O3 |
|---|---|
| Molecular Weight | 89.05470 |
| Exact Mass | 89.01940 |
| PSA | 54.37000 |
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| RIDADR | UN 3265 8 / PGII |
| Flash Point(F) | 179.6 °F |
| Flash Point(C) | 82 °C |
|
~97%
Pyruvic acid-13C CAS#:99124-30-8 |
| Literature: Spectra Gases, Inc. Patent: US2008/161593 A1, 2008 ; Location in patent: Page/Page column 11-12 ; |
|
~79%
Pyruvic acid-13C CAS#:99124-30-8 |
| Literature: AMERSHAM HEALTH AS Patent: WO2006/38811 A1, 2006 ; Location in patent: Page/Page column 7; 8 ; |
|
~%
Pyruvic acid-13C CAS#:99124-30-8 |
| Literature: The Regents of the University of California Patent: US2006/178534 A1, 2006 ; Location in patent: Page/Page column 4-5 ; |
![benzyl [1-(13)C]pyruvate structure](https://www.chemsrc.com/caspic/440/1002320-00-4.png)
|
Using [1-(13) C]lactic acid for hyperpolarized (13) C MR cardiac studies.
Magn. Reson. Med. , doi:10.1002/mrm.2535, (2014) Hyperpolarized [1-(13) C]lactate in solution may be a clinically relevant and safe substrate for real time MR investigations of key metabolic pathways. The potential of using hyperpolarized [1-(13) C]... |
|
|
Enhancing the [13C]bicarbonate signal in cardiac hyperpolarized [1-13C]pyruvate MRS studies by infusion of glucose, insulin and potassium.
NMR Biomed. 26(11) , 1496-500, (2013) A change in myocardial metabolism is a known effect of several diseases. MRS with hyperpolarized (13)C-labelled pyruvate is a technique capable of detecting changes in myocardial pyruvate metabolism, ... |
| 2-Oxopropionic acid-1-13C |
| |A-Ketopropionic acid-1-13C |
| Pyruvic-1-13C acid (free acid) |
| Pyruvic acid-1-13C |
| 13C Labeled pyruvic acid |
| PYRUVIC-1-13C ACID (FREE ACID) |